Nicorandil inhibits degranulation and TNF-α release from RBL-2H3 cells

Inflammation Research

Volumn 51, Issue 4, 2002, Pages 176-181

  Heywood, G J ^a   Thomas, P S ^a,b  

^a Faculty of Medicine   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Asthma; Mast cells; Nicorandil; Potassium channel openers; TNF

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2,4 DINITROPHENOL; ALBUMIN; BETA N ACETYLHEXOSAMINIDASE; CALCIUM ION; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; HEMOGLOBIN; IMMUNOGLOBULIN E RECEPTOR; N (2 ACETOXYETHYL)NICOTINAMIDE; NICORANDIL; NITRIC OXIDE; NITRIC OXIDE DONOR; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; MAST CELL DEGRANULATION; MAST CELL LEUKEMIA; NONHUMAN; RAT; SMOOTH MUSCLE RELAXATION;

EID: 0036234630     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000289     Document Type: Article

References (46)

1. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
2. Authentic 17 kDa tumour necrosis factor alpha is synthesized and released by canine mast cells and up-regulated by stem cell factor
3. Tumour necrosis factor alpha: A potential mediator of asthma
4. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects
5. Tumour necrosis factor causes bronchial hyperresponsiveness in rats
6. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor
7. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium
8. Tumour necrosis factor alpha: The role of this multifunctional cytokine in asthma
9. Airway structure and inflammatory cells in fatal attacks of asthma
10. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions
11. Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma
12. Superoxide generation and its modulation by adenosine in the neutrophils of subjects with asthma
13. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate
14. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats
15. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil
16. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the femoral artery
17. Potassium channels and airway function: New therapeutic prospects
18. Potassium channel activation and relaxation by nicorandil in rat small mesenteric arteries
19. 86Rb flux studies in rabbit isolated vascular smooth muscle
20. The relaxant action of nicorandil in guinea-pig isolated trachealis
21. Evaluation of the potassium channel activator cromakalim (BRL 34915) as a bronchodilator in the guinea-pig: Comparison with nifedipine
22. Effects of pinacidil on guinea-pig airway smooth muscle contracted by asthma mediators
23. Actions of nicorandil on vascular smooth muscles
24. Effects of nicorandil and its congeners on musculature and vasculature of the dog trachea in situ
25. Potassium channel openers inhibit ATP-induced cytosolic free calcium increase in cultured rabbit aortic smooth muscle cells
26. Physiological roles and properties of potassium channels in arterial smooth muscle
27. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris
28. + channels and cyclic GMP as components of vasodilation by nicorandil
29. Alterations in macrophage free radical and tumor necrosis factor production by a potassium channel activator
30. Exogenous nitric oxide regulates the degranulation of human basophils and rat peritoneal mast cells
31. Reciprocal effects of interleukin-4 and interferon-gamma on immunoglobulin E-mediated mast cell degranulation: A role for nitric oxide but not peroxynitrite or cyclic guanosine monophosphate
32. Specific signalling pathways in the regulation of TNFα mRNA synthesis and TNFα secretion in RBL-2H3 mast cells stimulated through the high affinity IgE receptor
33. 2+ indicators with greatly improved fluorescence properties
34. Comparative effects of nicorandil and nitroglycerin on tracheal and vascular smooth muscle in the dog, in vivo and in vitro
35. The effects of cromakalim on the mediator releases from guinea pig lung mast cell activated by specific antigen-antibody reactions
36. Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-gamma-induced suppression of exocytosis
37. Interferon-gamma regulates the interaction of RBL-2H3 cells with fibronectin through production of nitric oxide
38. 2-Nicotinamidoethyl acetate (SG-209) is a potassium channel opener: Structure activity relationship among nicorandil derivatives
39. Phenotypic variation in mast cell responsiveness to the inhibitory action of nitric oxide
40. Effect of cromakalim on bronchoconstriction evoked by cholinergic nerve stimulation in guinea-pig isolated trachea
41. Inhibition of histamine induced bronchoconstriction in normal healthy volunteers by a potassium channel activator, cromakalim, BRL 34915
42. Nitrovasodilator-induced relaxation in guinea pig vascular and tracheal smooth muscle
43. Differential effects of nitrovasodilators and nitric oxide on porcine tracheal and bronchial muscle in vitro
44. Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery
45. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75)
46. Pharmacokinetics of nicorandil